Early Access — free while we kick the tires
EdgarHawk

Rubenstein David M.

Director

Director
2 filings analyzed · 1 company · Latest 2026-03-20

Companies

Company Buys Sells Direction
Carlyle Group Inc. CG 0 4 Net selling

Activity

March 2026
2026-03-20 Carlyle Group Inc. CG
high
Sell
500,000 shares
$23,340,000
Significance 6/10

Director David M. Rubenstein sells 500,000 shares of Carlyle Group (CG) for $23.3M at $46.68, retaining 27.40M shares.

Rubenstein sold 500,000 shares (1.8% of pre-transaction holdings) at $46.68 on 2026-03-19. The stock has since declined 32.0% from its 52-week high of $69.35 and is down 14.2% over the trailing 30 days and 20.8% over 90 days. His prior sell at this ticker on 2025-12-10 achieved a 90-day return of -14.3%, consistent with a well-timed exit before the subsequent decline. His cross-ticker track record shows a 100.00% well-timed sell rate at the 90-day mark, with an average 90-day return of -14.3% following his sells—indicating a pattern of selling ahead of downturns. The company's fundamentals show annual revenue decline of -11.9%, a P/E of 37.70, and net income of only $900,000 on quarterly revenue of $332.7M, suggesting margin pressure. The magnitude of this sale ($23.3M) and Rubenstein's demonstrated track record of well-timed exits merit attention as the stock continues to underperform.

December 2025
2025-12-12 Carlyle Group Inc. CG
high
Sell
625,000 shares
$35,343,750
Significance 6/10

David M. Rubenstein (Director) sold 625,000 shares of CG at $56.55 on 2025-12-10; retains 27,999,644 shares.

Director David M. Rubenstein sold 625,000 shares (representing -2.2% of his pre-transaction holdings) at $56.55, a price that sits -15.9% below the 52-week high of $69.35, though the stock has recovered +6.0% over the past 30 days. The sale reduces his stake from 28,624,644 shares to 27,999,644 shares while maintaining substantial ownership. Carlyle Group posted strong fundamentals with annual revenue growth of +83.1% and a market cap of $21.0B, though current P/E stands at 31.71 against net income of $900,000 in the latest quarter. The transaction's significance lies in the scale—$35.3M in proceeds—and Rubenstein's position as a co-founder and controlling shareholder; the modest percentage reduction suggests ongoing portfolio management rather than a fundamental shift in conviction, yet the execution near recent weakness (relative to the 52-week peak) warrants attention to broader market and company context.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access